[Significance of the uPA/uPAR system for development of arteriosclerosis and restenosis].
Arteriosclerosis and the development of restenosis still remain a significant clinical problem. Migration of vascular smooth muscle cells from the media to the intima and cell proliferation are the hallmarks of the underlying pathomechanisms. Cell migration requires chemotaxis, phenotypic changes of cells, cell adhesive and de-adhesive events and the coordinated remodeling of the extracellular matrix. One of the phenotypic changes induced in migrating cells is the increased expression of urokinase plasminogen activator (uPA) and of its specific receptor uPAR. They are polarized to the leading edge of migrating cells. Both uPA and uPAR are key mediators of extracellular proteolysis. They participate in extracellular matrix remodeling, activate cells and enable them to migrate and invade into different tissue layers. UPA/uPAR are multifunctional proteins influencing a great variety of signal transduction pathways ultimately culminating in the regulation of cell migration and proliferation. In addition to time- and space-confined proteolysis this powerful system can mediate chemotaxis, cell adhesion and gene expression, partly by interacting in concert with integrins, G proteins, or with yet unidentified coreceptors or adapter molecules. Interaction with the uPA/uPAR system or components of its specific signal transduction pathways may serve as a guide for the development of effective therapeutic strategies to prevent arteriosclerosis and restenosis after percutaneous arterial angioplastic interventions.
Kusch
A
A
Franz-Volhard-Klinik am Max-Delbrück-Zentrum für Molekulare Medizin Wiltbergstr. 50 13125 Berlin, Germany. kusch@fvk-berlin.de
Gulba
D C
DC
D000818:Animals; D001161:Arteriosclerosis / Q000503:physiopathology* / Q000628:therapy; D002455:Cell Division / Q000502:physiology; D002465:Cell Movement / Q000502:physiology; D003324:Coronary Artery Disease / Q000503:physiopathology* / Q000628:therapy; D006801:Humans; D009131:Muscle, Smooth, Vascular / Q000503:physiopathology; D011956:Receptors, Cell Surface / Q000502:physiology*; D010959:Tissue Plasminogen Activator / Q000502:physiology*
D011956:Receptors, Cell Surface; C067262:PLAT protein, human; D010959:Tissue Plasminogen Activator